These innovative medications , Tirzepatide , represent a remarkable advancement in managing type 2 diabetes and conceivably associated conditions . These drugs are classified as GLP-1 pathway activators , meaning they to emulate the endogenous GLP-1 substance , boosting metabolic release and reducing hunger . While Semaglutide each works relatively